Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.
J Pharm Pharm Sci. 2021;24:343-350. doi: 10.18433/jpps32105.
J Pharm Pharm Sci. 2021.
PMID: 34265236
Free article.
Clinical Trial.